Literature DB >> 27038372

P2X7 Receptor as a Therapeutic Target.

Elena De Marchi1, Elisa Orioli1, Diego Dal Ben2, Elena Adinolfi3.   

Abstract

P2X7 receptor is an ATP-gated cation channel that upon agonist interaction leads to cellular influx of Na(+) and Ca(2+) and efflux of K(+). P2X7 is expressed by a wide variety of cells and its activation mediates a large number of biological processes like inflammation, neuromodulation, cell death or cell proliferation and it has been associated to related pathological conditions including infectious, inflammatory, autoimmune, neurological, and musculoskeletal disorders and, in the last years, to cancer. This chapter describes structural features of P2X7, chemical properties of its agonist, antagonist, and allosteric modulators and summarizes recent advances on P2X7 receptor as therapeutic target in the aforementioned diseases. We also give an overview on recent literature suggesting that P2X7 single-nucleotide polymorphisms could be exploited as diagnostic biomarkers for the development of tailored therapies.
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP; Cancer; Inflammation; Ligands; Mood disorders; Neurodegeneration; Osteoporosis; P2X7; SNPs

Mesh:

Substances:

Year:  2016        PMID: 27038372     DOI: 10.1016/bs.apcsb.2015.11.004

Source DB:  PubMed          Journal:  Adv Protein Chem Struct Biol        ISSN: 1876-1623            Impact factor:   3.507


  38 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

2.  The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease.

Authors:  N J Geraghty; L Belfiore; D Ly; S R Adhikary; S J Fuller; W Varikatt; M L Sanderson-Smith; V Sluyter; S I Alexander; R Sluyter; D Watson
Journal:  Clin Exp Immunol       Date:  2017-07-24       Impact factor: 4.330

3.  P2X7 PET Radioligand 18F-PTTP for Differentiation of Lung Tumor from Inflammation.

Authors:  Zhequan Fu; Qingyu Lin; Bingxin Hu; Yingying Zhang; Weijia Chen; Jing Zhu; Yanzhao Zhao; Hak Soo Choi; Hongcheng Shi; Dengfeng Cheng
Journal:  J Nucl Med       Date:  2019-01-17       Impact factor: 10.057

4.  The P2X7 receptor (P2X7R)-specific antagonist A804598 inhibits inflammatory reaction in human fibroblast-like synoviocytes.

Authors:  Yu Liu; Yongwei Wu; Sanjun Gu; Qudong Yin; Haifeng Li; Jian Wang; Dechun Geng; Yaozeng Xu
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

5.  Moringa oleifera modulates cholinergic and purinergic enzymes activity in BV-2 microglial cells.

Authors:  Stephen Adeniyi Adefegha; Charles Elias Assmann; Maria Rosa Chitolina Schetinger; Cinthia Melazzo de Andrade; Tatiana Emanuelli
Journal:  Metab Brain Dis       Date:  2021-01-04       Impact factor: 3.584

Review 6.  Purinergic signaling and tumor microenvironment in cervical Cancer.

Authors:  Marta Schmidt Pfaffenzeller; Maria Luiza Mukai Franciosi; Andréia Machado Cardoso
Journal:  Purinergic Signal       Date:  2020-03-13       Impact factor: 3.765

Review 7.  Role of purines in regulation of metabolic reprogramming.

Authors:  Zhenwei Tang; Wenrui Ye; Haotian Chen; Xinwei Kuang; Jia Guo; Minmin Xiang; Cong Peng; Xiang Chen; Hong Liu
Journal:  Purinergic Signal       Date:  2019-09-06       Impact factor: 3.765

Review 8.  Role of microglia in ischemic focal stroke and recovery: focus on Toll-like receptors.

Authors:  Jenni E Anttila; Keith W Whitaker; Emily S Wires; Brandon K Harvey; Mikko Airavaara
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-07-04       Impact factor: 5.067

Review 9.  Autocrine and paracrine purinergic signaling in the most lethal types of cancer.

Authors:  M Reyna-Jeldes; M Díaz-Muñoz; J A Madariaga; C Coddou; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2021-05-12       Impact factor: 3.765

10.  The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing-a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking.

Authors:  Mateusz Adamiak; Kamila Bujko; Arjun Thapa; Valentina Pensato; Katarzyna Brzezniakiewicz-Janus; Janina Ratajczak; Daryl L Davies; Henning Ulrich; Magda Kucia; Mariusz Z Ratajczak
Journal:  Leukemia       Date:  2021-07-20       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.